MedTrace Logo

CES for the Treatment of GAD in Young Adults

NCT06124014 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2026-03-18

No results posted yet for this study

Summary

The purpose of this research study is to study cranial electrotherapy stimulation (CES) to determine its effects on symptoms of anxiety in people with generalized anxiety disorder (GAD) between the ages of 18 - 21 years of age.

Conditions

  • Generalized Anxiety Disorder

Interventions

DEVICE

At-Home Stimulation

The stimulation paradigm in this trial consists of six weeks of daily, 60-minute at-home stimulation sessions.

Sponsors & Collaborators

  • University of North Carolina, Chapel Hill

    collaborator OTHER

  • Electromedical Products International, Inc.

    lead INDUSTRY

Principal Investigators

  • Samantha Meltzer-Brody, MD · University of North Carolina, Chapel Hill

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-26
Primary Completion
2025-12-17
Completion
2026-01-21
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06124014 on ClinicalTrials.gov